25 XP   0   0   10

Catalyst Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyse Catalyst Pharmaceuticals Inc together

PenkeI guess you are interested in Catalyst Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Catalyst Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Catalyst Pharmaceuticals Inc

I send you an email if I find something interesting about Catalyst Pharmaceuticals Inc.

Quick analysis of Catalyst Pharmaceuticals Inc (30 sec.)










What can you expect buying and holding a share of Catalyst Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$4.55
Expected worth in 1 year
$6.27
How sure are you?
57.5%

+ What do you gain per year?

Total Gains per Share
$1.72
Return On Investment
10.9%

For what price can you sell your share?

Current Price per Share
$15.80
Expected price per share
$13.12 - $17.03
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of Catalyst Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)

$15.80

Intrinsic Value Per Share

$-118.05 - $18.64

Total Value Per Share

$-113.50 - $23.19

2. Growth of Catalyst Pharmaceuticals Inc (5 min.)




Is Catalyst Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$561.4m$286.3m$131.9m31.6%

How much money is Catalyst Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money$16.2m$24.8m-$8.5m-52.7%
Net Profit Margin15.8%39.3%--

How much money comes from the company's main activities?

3. Financial Health of Catalyst Pharmaceuticals Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#100 / 968

Most Revenue
#70 / 968

Most Profit
#57 / 968
3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of Catalyst Pharmaceuticals Inc? (5 min.)

Welcome investor! Catalyst Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of Catalyst Pharmaceuticals Inc.

What can you expect buying and holding a share of Catalyst Pharmaceuticals Inc?

First you should know what it really means to hold a share of Catalyst Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of Catalyst Pharmaceuticals Inc is $15.80. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Catalyst Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Catalyst Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $4.55. Based on the TTM, the Book Value Change Per Share is $0.43 per quarter. Based on the YOY, the Book Value Change Per Share is $0.24 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Catalyst Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.191.2%0.140.9%0.211.3%0.140.9%0.050.3%
Usd Book Value Change Per Share1.278.0%0.432.7%0.241.5%0.211.3%0.110.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share1.278.0%0.432.7%0.241.5%0.211.3%0.110.7%
Usd Price Per Share15.94-14.47-13.76-8.57-5.64-
Price to Earnings Ratio21.13-8.67-16.09-12.86--6.79-
Price-to-Total Gains Ratio12.60-12.40-55.81-44.18-24.05-
Price to Book Ratio3.50-4.20-5.56-4.57-5.50-
Price-to-Total Gains Ratio12.60-12.40-55.81-44.18-24.05-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share15.8
Number of shares63
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.430.21
Usd Total Gains Per Share0.430.21
Gains per Quarter (63 shares)27.1612.97
Gains per Year (63 shares)108.6451.86
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101099905242
20217208010494
303263170156146
404354260207198
505435350259250
606526440311302
707617530363354
808698620415406
909789710467458
100108610800519510

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%11.01.00.091.7%19.01.00.095.0%19.021.00.047.5%19.055.00.025.7%
Book Value Change Per Share3.01.00.075.0%11.01.00.091.7%19.01.00.095.0%23.017.00.057.5%35.037.02.047.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.074.00.0%
Total Gains per Share3.01.00.075.0%11.01.00.091.7%19.01.00.095.0%23.017.00.057.5%35.037.02.047.3%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of Catalyst Pharmaceuticals Inc

About Catalyst Pharmaceuticals Inc

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was founded in 2002 and is based in Coral Gables, Florida.

Fundamental data was last updated by Penke on 2024-06-17 18:12:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of Catalyst Pharmaceuticals Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Catalyst Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Catalyst Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 23.6% means that $0.24 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Catalyst Pharmaceuticals Inc:

  • The MRQ is 23.6%. The company is making a huge profit. +2
  • The TTM is 15.8%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ23.6%TTM15.8%+7.9%
TTM15.8%YOY39.3%-23.5%
TTM15.8%5Y36.2%-20.5%
5Y36.2%10Y-54.5%+90.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ23.6%-166.0%+189.6%
TTM15.8%-209.9%+225.7%
YOY39.3%-242.8%+282.1%
5Y36.2%-405.7%+441.9%
10Y-54.5%-534.4%+479.9%
1.1.2. Return on Assets

Shows how efficient Catalyst Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Catalyst Pharmaceuticals Inc to the Biotechnology industry mean.
  • 3.6% Return on Assets means that Catalyst Pharmaceuticals Inc generated $0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Catalyst Pharmaceuticals Inc:

  • The MRQ is 3.6%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.6%TTM3.0%+0.6%
TTM3.0%YOY7.2%-4.2%
TTM3.0%5Y7.3%-4.3%
5Y7.3%10Y-1.0%+8.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6%-11.9%+15.5%
TTM3.0%-11.9%+14.9%
YOY7.2%-11.3%+18.5%
5Y7.3%-13.5%+20.8%
10Y-1.0%-14.9%+13.9%
1.1.3. Return on Equity

Shows how efficient Catalyst Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Catalyst Pharmaceuticals Inc to the Biotechnology industry mean.
  • 4.1% Return on Equity means Catalyst Pharmaceuticals Inc generated $0.04 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Catalyst Pharmaceuticals Inc:

  • The MRQ is 4.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.6%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ4.1%TTM3.6%+0.6%
TTM3.6%YOY8.7%-5.1%
TTM3.6%5Y8.7%-5.1%
5Y8.7%10Y-0.9%+9.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1%-14.2%+18.3%
TTM3.6%-15.7%+19.3%
YOY8.7%-14.3%+23.0%
5Y8.7%-19.2%+27.9%
10Y-0.9%-19.7%+18.8%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of Catalyst Pharmaceuticals Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Catalyst Pharmaceuticals Inc is operating .

  • Measures how much profit Catalyst Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Catalyst Pharmaceuticals Inc to the Biotechnology industry mean.
  • An Operating Margin of 27.5% means the company generated $0.28  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Catalyst Pharmaceuticals Inc:

  • The MRQ is 27.5%. The company is operating very efficient. +2
  • The TTM is 19.0%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ27.5%TTM19.0%+8.6%
TTM19.0%YOY47.3%-28.3%
TTM19.0%5Y35.0%-16.1%
5Y35.0%10Y-57.0%+92.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ27.5%-360.7%+388.2%
TTM19.0%-225.9%+244.9%
YOY47.3%-252.2%+299.5%
5Y35.0%-428.3%+463.3%
10Y-57.0%-531.1%+474.1%
1.2.2. Operating Ratio

Measures how efficient Catalyst Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.72 means that the operating costs are $0.72 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Catalyst Pharmaceuticals Inc:

  • The MRQ is 0.725. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.810. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.725TTM0.810-0.086
TTM0.810YOY0.525+0.285
TTM0.8105Y0.648+0.162
5Y0.64810Y1.118-0.470
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7253.024-2.299
TTM0.8103.353-2.543
YOY0.5253.502-2.977
5Y0.6485.271-4.623
10Y1.1186.915-5.797
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of Catalyst Pharmaceuticals Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Catalyst Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 5.09 means the company has $5.09 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Catalyst Pharmaceuticals Inc:

  • The MRQ is 5.085. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.970. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.085TTM3.970+1.115
TTM3.970YOY6.512-2.542
TTM3.9705Y6.677-2.707
5Y6.67710Y12.215-5.539
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.0853.767+1.318
TTM3.9704.000-0.030
YOY6.5124.905+1.607
5Y6.6775.883+0.794
10Y12.2156.280+5.935
1.3.2. Quick Ratio

Measures if Catalyst Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Catalyst Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Quick Ratio of 4.66 means the company can pay off $4.66 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Catalyst Pharmaceuticals Inc:

  • The MRQ is 4.662. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.580. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.662TTM3.580+1.082
TTM3.580YOY6.302-2.722
TTM3.5805Y6.803-3.223
5Y6.80310Y17.561-10.758
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.6623.054+1.608
TTM3.5803.506+0.074
YOY6.3024.756+1.546
5Y6.8035.757+1.046
10Y17.5616.338+11.223
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of Catalyst Pharmaceuticals Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Catalyst Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Catalyst Pharmaceuticals Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.13 means that Catalyst Pharmaceuticals Inc assets are financed with 13.2% credit (debt) and the remaining percentage (100% - 13.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Catalyst Pharmaceuticals Inc:

  • The MRQ is 0.132. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.155. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.132TTM0.155-0.023
TTM0.155YOY0.167-0.012
TTM0.1555Y0.148+0.007
5Y0.14810Y0.119+0.030
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1320.330-0.198
TTM0.1550.342-0.187
YOY0.1670.287-0.120
5Y0.1480.368-0.220
10Y0.1190.382-0.263
1.4.2. Debt to Equity Ratio

Measures if Catalyst Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Catalyst Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 15.2% means that company has $0.15 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Catalyst Pharmaceuticals Inc:

  • The MRQ is 0.152. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.184. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.152TTM0.184-0.032
TTM0.184YOY0.203-0.019
TTM0.1845Y0.176+0.008
5Y0.17610Y0.139+0.037
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1520.366-0.214
TTM0.1840.415-0.231
YOY0.2030.370-0.167
5Y0.1760.443-0.267
10Y0.1390.476-0.337
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of Catalyst Pharmaceuticals Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Catalyst Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare Catalyst Pharmaceuticals Inc to the Biotechnology industry mean.
  • A PE ratio of 21.13 means the investor is paying $21.13 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Catalyst Pharmaceuticals Inc:

  • The EOD is 20.943. Based on the earnings, the company is fair priced.
  • The MRQ is 21.128. Based on the earnings, the company is fair priced.
  • The TTM is 8.666. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD20.943MRQ21.128-0.186
MRQ21.128TTM8.666+12.463
TTM8.666YOY16.088-7.422
TTM8.6665Y12.857-4.191
5Y12.85710Y-6.793+19.650
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD20.943-2.399+23.342
MRQ21.128-2.997+24.125
TTM8.666-2.882+11.548
YOY16.088-3.553+19.641
5Y12.857-6.269+19.126
10Y-6.793-6.289-0.504
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Catalyst Pharmaceuticals Inc:

  • The EOD is 15.364. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 15.500. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 10.926. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD15.364MRQ15.500-0.136
MRQ15.500TTM10.926+4.575
TTM10.926YOY17.989-7.064
TTM10.9265Y14.019-3.094
5Y14.01910Y-2.180+16.199
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD15.364-2.907+18.271
MRQ15.500-3.739+19.239
TTM10.926-3.766+14.692
YOY17.989-4.886+22.875
5Y14.019-7.921+21.940
10Y-2.180-8.564+6.384
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Catalyst Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.50 means the investor is paying $3.50 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Catalyst Pharmaceuticals Inc:

  • The EOD is 3.473. Based on the equity, the company is fair priced.
  • The MRQ is 3.504. Based on the equity, the company is fair priced.
  • The TTM is 4.204. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.473MRQ3.504-0.031
MRQ3.504TTM4.204-0.700
TTM4.204YOY5.557-1.354
TTM4.2045Y4.572-0.369
5Y4.57210Y5.498-0.925
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.4731.842+1.631
MRQ3.5042.249+1.255
TTM4.2042.301+1.903
YOY5.5572.412+3.145
5Y4.5723.782+0.790
10Y5.4984.212+1.286
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Catalyst Pharmaceuticals Inc.

3.1. Institutions holding Catalyst Pharmaceuticals Inc

Institutions are holding 83.33% of the shares of Catalyst Pharmaceuticals Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-31BlackRock Inc15.0130.006617732642191034312.0737
2024-03-31Deerfield Management Co7.73042.5321913081793881711.4602
2024-03-31State Street Corporation6.90250.00588152902136557020.1194
2024-03-31Vanguard Group Inc6.75670.0025798066186024412.0814
2024-03-31Dimensional Fund Advisors, Inc.2.31780.011827376571358605.2218
2024-03-31HHG PLC2.30820.023727263881587794139.4522
2024-03-31Geode Capital Management, LLC2.12350.0037250815230792713.9953
2024-03-31Royce & Associates, LP1.76440.2965208401334093919.5596
2024-03-31Renaissance Technologies Corp1.59880.0473188842729100018.2168
2024-03-31Morgan Stanley - Brokerage Accounts1.5230.00231798856-162683-8.2936
2024-03-31Marshall Wace Asset Management Ltd1.42570.0409168395116839510
2024-03-31Boston Partners Global Investors, Inc1.27580.02831506930-34730-2.2528
2024-03-31Northern Trust Corp1.21050.00391429748110070.7758
2024-03-31Jacobs Levy Equity Management, Inc.1.06330.08951255880-51345-3.9278
2024-03-31T. Rowe Price Associates, Inc.1.03240.00241219418228601.9105
2024-03-31VOLORIDGE INVESTMENT MANAGEMENT, LLC0.91690.06311083037682878170.6517
2024-03-31Charles Schwab Investment Management Inc0.91060.004107555911922612.467
2024-03-31Kennedy Capital Management Inc0.89890.34821061704533802101.1176
2024-03-31Opaleye Management Inc0.85033.4891004355-252845-20.1118
2024-03-31Goldman Sachs Group Inc0.84770.00281001281-915545-47.7636
Total 58.47047.004469062378+9375070+13.6%

3.2. Funds holding Catalyst Pharmaceuticals Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-05-30iShares Core S&P Small-Cap ETF6.34980.15397500124-1887-0.0252
2024-05-31SPDR® S&P Biotech ETF3.31970.9533921041-46234-1.1654
2024-04-30Vanguard Total Stock Mkt Idx Inv2.99610.00353538816515681.4788
2024-05-30iShares Russell 2000 ETF2.15540.06942545882193600.7663
2024-05-30First Trust NYSE Arca Biotech ETF2.02663.4754239377400
2024-04-30Vanguard Institutional Extnd Mkt Idx Tr1.40560.02541660274-295-0.0178
2024-03-31Fidelity Small Cap Index0.94630.06651117703926459.038
2024-05-30iShares S&P Small-Cap 600 Growth ETF0.92530.29921092904-1209-0.1105
2024-05-31SPDR® Portfolio S&P 600™ Sm Cap ETF0.83720.152398881922220.2252
2024-05-30iShares Russell 2000 Growth ETF0.79650.138594081200
2024-03-31T. Rowe Price Integrated US Sm Gr Eq0.75390.1676890500155001.7714
2024-04-30Vanguard Tax-Managed Small Cap Adm0.73020.15186243500
2024-04-30DFA US Micro Cap I0.60420.157171368300
2024-05-31State St Russell Sm/Mid Cp® Indx NL Cl C0.57670.026268117100
2024-03-31Janus Henderson Global Life Sciences0.56950.20016727016727010
2024-04-30Janus Henderson Global Life Sciences D0.56690.1981669582-3119-0.4637
2024-04-30Fidelity Extended Market Index0.53590.0261632996-15828-2.4395
2024-05-31SPDR® S&P 600 Small Cap Growth ETF0.51950.301861359340550.6653
2024-04-30DFA US Small Cap I0.49040.057957928900
2024-03-31Royce Small-Cap Fund Invmt0.48390.4652571578383997.2019
Total 27.58967.088232587677+827878+2.5%

3.3. Insider Transactions

Insiders are holding 6.208% of the shares of Catalyst Pharmaceuticals Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-06-07Carmen Jeffrey DelSELL754116.07
2024-06-05Gary IngenitoSELL8000016.16
2024-06-04Richard J DalySELL1732315.97
2024-06-03Molly HarperSELL533316.3
2024-04-08David S TierneySELL2500015.68
2024-03-27Brian ElsberndSELL2500016.44
2023-12-12David S TierneySELL5000013.32
2023-12-11Alicia GrandeSELL6000013.76
2023-12-08Alicia GrandeSELL4000014.28
2023-12-05Steve MillerSELL4000014.24
3rd party ad coffee SUPPORTERis ad-free.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Catalyst Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.2650.431+194%0.240+427%0.206+515%0.110+1050%
Book Value Per Share--4.5493.490+30%2.424+88%1.928+136%1.182+285%
Current Ratio--5.0853.970+28%6.512-22%6.677-24%12.215-58%
Debt To Asset Ratio--0.1320.155-15%0.167-21%0.148-11%0.119+11%
Debt To Equity Ratio--0.1520.184-18%0.203-25%0.176-14%0.139+9%
Dividend Per Share----0%-0%-0%-0%
Eps--0.1890.136+39%0.210-10%0.137+38%0.047+304%
Free Cash Flow Per Share--0.2570.098+161%0.251+2%-8.064+3236%-4.052+1676%
Free Cash Flow To Equity Per Share--1.4000.361+288%0.258+443%-8.013+672%-3.995+385%
Gross Profit Margin---0.0880.575-115%0.606-115%0.611-114%0.805-111%
Intrinsic Value_10Y_max--18.643--------
Intrinsic Value_10Y_min---118.054--------
Intrinsic Value_1Y_max--0.826--------
Intrinsic Value_1Y_min---15.563--------
Intrinsic Value_3Y_max--3.277--------
Intrinsic Value_3Y_min---43.804--------
Intrinsic Value_5Y_max--6.685--------
Intrinsic Value_5Y_min---68.588--------
Market Cap1866217000.000-5%1967053798.4401730199224.610+14%1624671825.000+21%1015870009.922+94%667980829.961+194%
Net Profit Margin--0.2360.158+50%0.393-40%0.362-35%-0.545+331%
Operating Margin--0.2750.190+45%0.473-42%0.350-21%-0.570+307%
Operating Ratio--0.7250.810-11%0.525+38%0.648+12%1.118-35%
Pb Ratio3.473-1%3.5044.204-17%5.557-37%4.572-23%5.498-36%
Pe Ratio20.943-1%21.1288.666+144%16.088+31%12.857+64%-6.793+132%
Price Per Share15.800-1%15.94014.470+10%13.755+16%8.565+86%5.638+183%
Price To Free Cash Flow Ratio15.364-1%15.50010.926+42%17.989-14%14.019+11%-2.180+114%
Price To Total Gains Ratio12.485-1%12.59612.395+2%55.813-77%44.183-71%24.048-48%
Quick Ratio--4.6623.580+30%6.302-26%6.803-31%17.561-73%
Return On Assets--0.0360.030+20%0.072-50%0.073-51%-0.010+129%
Return On Equity--0.0410.036+15%0.087-52%0.087-52%-0.009+121%
Total Gains Per Share--1.2650.431+194%0.240+427%0.206+515%0.110+1050%
Usd Book Value--561412000.000418283750.000+34%286303750.000+96%228882735.700+145%140260628.725+300%
Usd Book Value Change Per Share--1.2650.431+194%0.240+427%0.206+515%0.110+1050%
Usd Book Value Per Share--4.5493.490+30%2.424+88%1.928+136%1.182+285%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.1890.136+39%0.210-10%0.137+38%0.047+304%
Usd Free Cash Flow--31726000.00011952750.000+165%29628750.000+7%-952363052.100+3102%-478533650.775+1608%
Usd Free Cash Flow Per Share--0.2570.098+161%0.251+2%-8.064+3236%-4.052+1676%
Usd Free Cash Flow To Equity Per Share--1.4000.361+288%0.258+443%-8.013+672%-3.995+385%
Usd Market Cap1866217000.000-5%1967053798.4401730199224.610+14%1624671825.000+21%1015870009.922+94%667980829.961+194%
Usd Price Per Share15.800-1%15.94014.470+10%13.755+16%8.565+86%5.638+183%
Usd Profit--23275000.00016279250.000+43%24851500.000-6%16237442.000+43%5542127.350+320%
Usd Revenue--98509000.000102836750.000-4%64120000.000+54%53033985.100+86%26840703.500+267%
Usd Total Gains Per Share--1.2650.431+194%0.240+427%0.206+515%0.110+1050%
 EOD+4 -4MRQTTM+29 -5YOY+20 -145Y+22 -1210Y+25 -9

4.2. Fundamental Score

Let's check the fundamental score of Catalyst Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1520.943
Price to Book Ratio (EOD)Between0-13.473
Net Profit Margin (MRQ)Greater than00.236
Operating Margin (MRQ)Greater than00.275
Quick Ratio (MRQ)Greater than14.662
Current Ratio (MRQ)Greater than15.085
Debt to Asset Ratio (MRQ)Less than10.132
Debt to Equity Ratio (MRQ)Less than10.152
Return on Equity (MRQ)Greater than0.150.041
Return on Assets (MRQ)Greater than0.050.036
Total6/10 (60.0%)

4.3. Technical Score

Let's check the technical score of Catalyst Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.788
Ma 20Greater thanMa 5015.461
Ma 50Greater thanMa 10015.599
Ma 100Greater thanMa 20015.476
OpenGreater thanClose15.730
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets646,676
Total Liabilities85,264
Total Stockholder Equity561,412
 As reported
Total Liabilities 85,264
Total Stockholder Equity+ 561,412
Total Assets = 646,676

Assets

Total Assets646,676
Total Current Assets404,602
Long-term Assets242,074
Total Current Assets
Cash And Cash Equivalents 310,411
Net Receivables 60,493
Inventory 19,953
Other Current Assets 143
Total Current Assets  (as reported)404,602
Total Current Assets  (calculated)391,000
+/- 13,602
Long-term Assets
Property Plant Equipment 3,748
Long Term Investments 15,345
Intangible Assets 184,705
Long-term Assets  (as reported)242,074
Long-term Assets  (calculated)203,798
+/- 38,276

Liabilities & Shareholders' Equity

Total Current Liabilities79,566
Long-term Liabilities5,698
Total Stockholder Equity561,412
Total Current Liabilities
Short-term Debt 377
Accounts payable 10,261
Other Current Liabilities 631
Total Current Liabilities  (as reported)79,566
Total Current Liabilities  (calculated)11,269
+/- 68,297
Long-term Liabilities
Capital Lease Obligations 3,468
Long-term Liabilities Other 748
Long-term Liabilities  (as reported)5,698
Long-term Liabilities  (calculated)4,216
+/- 1,482
Total Stockholder Equity
Common Stock118
Retained Earnings 144,547
Other Stockholders Equity 416,747
Total Stockholder Equity (as reported)561,412
Total Stockholder Equity (calculated)561,412
+/-0
Other
Capital Stock118
Cash and Short Term Investments 310,411
Common Stock Shares Outstanding 123,404
Current Deferred Revenue68,297
Liabilities and Stockholders Equity 646,676
Net Debt -306,943
Net Invested Capital 561,412
Net Working Capital 325,036
Property Plant and Equipment Gross 4,556
Short Long Term Debt Total 3,468



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-31
> Total Assets 
0
0
0
185
0
0
0
789
0
365
3,512
20,619
20,619
18,247
17,593
16,680
15,489
13,535
15,348
12,033
9,248
6,481
5,078
7,966
7,037
5,911
6,415
5,831
7,156
5,610
4,298
6,249
4,989
7,704
12,105
16,789
16,789
12,545
28,695
25,370
22,230
45,929
45,845
43,908
76,050
68,337
64,563
60,102
53,666
48,941
45,313
41,707
37,697
35,980
34,631
85,387
79,128
74,288
67,710
60,450
61,077
78,234
96,691
112,376
117,880
131,412
174,860
192,354
197,216
209,130
223,248
237,788
246,972
267,309
333,114
375,630
407,227
443,896
413,211
471,907
646,676
646,676471,907413,211443,896407,227375,630333,114267,309246,972237,788223,248209,130197,216192,354174,860131,412117,880112,37696,69178,23461,07760,45067,71074,28879,12885,38734,63135,98037,69741,70745,31348,94153,66660,10264,56368,33776,05043,90845,84545,92922,23025,37028,69512,54516,78916,78912,1057,7044,9896,2494,2985,6107,1565,8316,4155,9117,0377,9665,0786,4819,24812,03315,34813,53515,48916,68017,59318,24720,61920,6193,5123650789000185000
   > Total Current Assets 
0
0
0
184
0
0
0
772
0
327
3,007
20,588
20,588
18,177
17,448
16,532
15,343
13,397
15,218
11,915
9,146
6,390
4,994
7,887
6,964
5,845
6,356
5,775
7,101
5,574
4,269
6,228
4,966
7,682
12,085
16,727
16,727
12,484
28,640
25,320
22,168
45,855
45,764
43,828
75,970
68,265
64,356
59,901
53,479
48,673
45,055
41,454
37,457
35,753
34,417
85,187
78,936
69,086
62,481
55,187
54,862
72,056
90,579
111,364
116,944
131,164
143,342
159,244
161,533
176,305
192,795
210,106
221,191
242,558
276,310
320,797
198,911
240,968
192,017
219,329
404,602
404,602219,329192,017240,968198,911320,797276,310242,558221,191210,106192,795176,305161,533159,244143,342131,164116,944111,36490,57972,05654,86255,18762,48169,08678,93685,18734,41735,75337,45741,45445,05548,67353,47959,90164,35668,26575,97043,82845,76445,85522,16825,32028,64012,48416,72716,72712,0857,6824,9666,2284,2695,5747,1015,7756,3565,8456,9647,8874,9946,3909,14611,91515,21813,39715,34316,53217,44818,17720,58820,5883,0073270772000184000
       Cash And Cash Equivalents 
0
0
0
184
0
0
0
771
0
324
3,003
20,435
20,435
17,600
16,886
15,944
14,717
13,084
15,027
11,767
8,930
6,266
4,912
7,779
6,758
5,608
6,247
5,475
6,873
3,406
2,151
6,029
4,723
7,515
11,974
1,410
1,410
879
12,963
2,216
1,072
14,802
11,264
9,097
41,323
37,221
32,750
28,235
22,228
18,717
17,638
13,893
9,981
8,584
7,329
57,497
19,601
9,888
10,616
16,559
19,082
23,418
44,983
89,512
101,751
115,052
117,106
130,237
127,328
135,295
154,836
171,445
178,372
210,912
256,065
298,395
148,247
178,787
120,971
137,636
310,411
310,411137,636120,971178,787148,247298,395256,065210,912178,372171,445154,836135,295127,328130,237117,106115,052101,75189,51244,98323,41819,08216,55910,6169,88819,60157,4977,3298,5849,98113,89317,63818,71722,22828,23532,75037,22141,3239,09711,26414,8021,0722,21612,9638791,4101,41011,9747,5154,7236,0292,1513,4066,8735,4756,2475,6086,7587,7794,9126,2668,93011,76715,02713,08414,71715,94416,88617,60020,43520,4353,0033240771000184000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,002
2,004
0
0
0
0
14,007
14,007
10,491
14,688
21,495
20,212
30,211
30,183
30,178
30,214
30,182
30,212
30,161
30,227
29,305
27,106
26,513
26,546
26,548
26,578
26,517
58,343
58,521
51,048
36,922
26,551
36,503
31,562
5,007
5,007
0
10,003
10,041
15,971
19,980
19,956
19,821
19,424
9,876
0
0
0
0
0
0
0
00000009,87619,42419,82119,95619,98015,97110,04110,00305,0075,00731,56236,50326,55136,92251,04858,52158,34326,51726,57826,54826,54626,51327,10629,30530,22730,16130,21230,18230,21430,17830,18330,21120,21221,49514,68810,49114,00714,00700002,0042,00200000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
86
86
79
66
64
41
24
17
12
3
0
0
0
0
0
0
134
134
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,500
3,500
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,251
10,376
10,095
10,537
6,919
6,762
6,179
5,987
6,005
9,209
6,822
6,619
10,784
9,804
9,661
10,439
33,402
42,796
48,049
53,514
60,493
60,49353,51448,04942,79633,40210,4399,6619,80410,7846,6196,8229,2096,0055,9876,1796,7626,91910,53710,09510,3767,2510000000000000003,5003,50000000000000000134134000000312172441646679868600000000000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
3
3
67
67
498
496
524
585
288
173
136
214
125
82
108
207
237
109
166
228
2,002
2,004
199
243
167
112
7,812
15
10
24
23
59
32
45
34
109
861
53
1,505
36
35
36
1,048
57
34
50
1,174
52
677
191
1,650
1,881
382
431
4,351
327
292
590
8,328
276
321
228
4,351
433
394
466
5,158
6,934
361
352
12,535
143
14312,5353523616,9345,1584663944334,3512283212768,3285902923274,3514313821,8811,650191677521,1745034571,0483635361,5055386110934453259232410157,8121121672431992,0042,00222816610923720710882125214136173288585524496498676733000000000
   > Long-term Assets 
0
0
0
1
0
0
0
18
0
38
505
0
32
70
146
148
146
138
130
118
101
91
84
79
72
66
60
56
55
36
29
21
23
22
20
63
63
61
55
50
62
74
80
80
80
72
207
200
187
267
258
253
240
227
214
200
192
5,201
5,229
5,263
6,215
6,178
6,111
1,013
936
248
31,518
33,110
35,683
32,825
30,453
27,682
25,781
24,751
56,804
54,833
208,316
202,928
221,194
252,578
242,074
242,074252,578221,194202,928208,31654,83356,80424,75125,78127,68230,45332,82535,68333,11031,5182489361,0136,1116,1786,2155,2635,2295,2011922002142272402532582671872002077280808074625055616363202223212936555660667279849110111813013814614814670320505380180001000
       Property Plant Equipment 
0
0
0
1
0
0
0
4
0
14
20
20
20
50
126
128
121
113
105
96
88
81
73
68
62
55
49
46
45
26
18
12
14
14
11
54
54
52
46
41
53
65
71
71
71
63
198
192
178
259
249
244
231
218
205
191
183
187
201
245
1,214
1,161
1,093
1,004
927
239
161
130
4,253
4,115
4,044
3,976
3,882
3,812
3,715
3,617
3,991
3,844
3,761
3,703
3,748
3,7483,7033,7613,8443,9913,6173,7153,8123,8823,9764,0444,1154,2531301612399271,0041,0931,1611,2142452011871831912052182312442492591781921986371717165534146525454111414121826454649556268738188961051131211281265020202014040001000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,005
5,019
5,008
4,992
5,008
5,009
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,897
16,489
15,345
15,34516,48912,8970000000000000005,0095,0084,9925,0085,0195,005000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
33,051
32,471
184,083
175,595
167,108
194,049
184,705
184,705194,049167,108175,595184,08332,47133,05100000000000000000000000000000000000000000000000000000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
13
0
24
485
11
20
20
20
20
25
25
25
22
13
11
11
11
11
11
11
11
10
11
11
9
9
8
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
31,356
32,980
31,430
28,710
26,409
23,706
21,899
20,939
20,038
18,745
0
23,489
0
0
0
00023,489018,74520,03820,93921,89923,70626,40928,71031,43032,98031,356999999999999999999999999999999998991111101111111111111113222525252020202011485240130000000
> Total Liabilities 
0
0
0
68
0
0
0
343
0
434
687
773
773
418
405
357
489
789
1,266
1,473
1,576
507
315
349
381
499
415
314
873
656
423
2,489
2,272
1,293
2,710
2,167
2,167
2,701
6,576
3,978
4,591
4,741
9,222
8,666
9,427
5,545
3,913
4,625
3,129
2,616
2,410
2,398
2,601
2,011
2,902
4,424
2,882
3,225
3,633
9,666
9,901
14,953
18,708
24,746
18,204
20,210
18,232
22,756
18,565
20,186
24,587
30,957
26,751
26,217
63,073
75,209
73,566
68,602
64,663
84,026
85,264
85,26484,02664,66368,60273,56675,20963,07326,21726,75130,95724,58720,18618,56522,75618,23220,21018,20424,74618,70814,9539,9019,6663,6333,2252,8824,4242,9022,0112,6012,3982,4102,6163,1294,6253,9135,5459,4278,6669,2224,7414,5913,9786,5762,7012,1672,1672,7101,2932,2722,4894236568733144154993813493155071,5761,4731,266789489357405418773773687434034300068000
   > Total Current Liabilities 
0
0
0
68
0
0
0
343
0
434
687
773
773
418
405
303
438
740
1,221
1,430
1,537
471
266
294
335
451
396
299
862
656
423
834
879
677
753
1,647
1,647
1,638
3,012
2,140
2,437
2,364
5,939
5,855
5,849
2,553
2,386
3,441
2,664
2,305
1,996
2,095
1,906
1,840
2,738
4,266
2,731
3,082
3,468
9,511
9,026
14,152
17,982
24,099
17,636
20,210
18,232
22,756
14,436
16,135
20,614
27,063
22,938
22,488
44,681
57,588
56,709
52,503
57,806
76,063
79,566
79,56676,06357,80652,50356,70957,58844,68122,48822,93827,06320,61416,13514,43622,75618,23220,21017,63624,09917,98214,1529,0269,5113,4683,0822,7314,2662,7381,8401,9062,0951,9962,3052,6643,4412,3862,5535,8495,8555,9392,3642,4372,1403,0121,6381,6471,6477536778798344236568622993964513352942664711,5371,4301,221740438303405418773773687434034300068000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
235
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
283
288
294
301
307
198
115
29
122
200
278
308
316
322
330
337
345
353
361
369
377
3773693613533453373303223163082782001222911519830730129428828300000000000000000000000000000235000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
283
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000283000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
31
0
0
0
68
0
25
418
448
448
146
229
220
317
181
636
333
738
276
163
250
88
252
241
106
425
478
174
264
350
223
356
1,647
1,366
448
1,473
851
932
1,238
525
1,814
1,051
1,316
817
1,794
1,251
707
1,055
933
918
692
1,082
1,946
805
923
1,341
2,337
2,940
3,329
4,147
4,117
1,348
5,805
2,005
4,256
2,561
2,924
2,752
2,768
5,139
2,315
2,529
3,975
3,391
4,421
4,598
14,795
10,261
10,26114,7954,5984,4213,3913,9752,5292,3155,1392,7682,7522,9242,5614,2562,0055,8051,3484,1174,1473,3292,9402,3371,3419238051,9461,0826929189331,0557071,2511,7948171,3161,0511,8145251,2389328511,4734481,3661,647356223350264174478425106241252882501632767383336361813172202291464484484182506800031000
       Other Current Liabilities 
0
0
0
37
0
0
0
275
0
409
269
324
325
272
176
83
122
559
585
1,097
799
195
103
45
246
199
155
193
437
178
9
570
529
454
397
282
281
1,189
1,538
1,289
1,505
1,126
5,414
4,041
4,798
1,237
1,569
1,646
1,412
1,598
940
1,161
988
1,148
1,656
2,321
1,926
2,159
2,127
7,174
166
153
531
172
140
31
70
107
111
112
110
243
17,483
19,851
41,822
53,276
52,973
455
374
60,170
631
63160,17037445552,97353,27641,82219,85117,48324311011211110770311401725311531667,1742,1272,1591,9262,3211,6561,1489881,1619401,5981,4121,6461,5691,2374,7984,0415,4141,1261,5051,2891,5381,1892812823974545295709178437193155199246451031957991,09758555912283176272325324269409027500037000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
54
51
49
46
43
40
36
50
54
47
47
19
15
11
0
0
1,655
1,393
616
1,957
520
520
1,063
3,564
1,839
2,155
2,377
3,283
2,811
3,578
2,991
1,527
1,185
465
310
414
303
695
171
165
157
150
143
165
155
875
801
726
648
568
0
0
0
4,129
4,051
3,973
3,894
3,813
3,729
18,392
17,621
16,857
16,099
6,857
7,963
5,698
5,6987,9636,85716,09916,85717,62118,3923,7293,8133,8943,9734,0514,1290005686487268018751551651431501571651716953034143104651,1851,5272,9913,5782,8113,2832,3772,1551,8393,5641,0635205201,9576161,3931,655001115194747545036404346495154000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
54
51
49
45
43
40
36
49
54
47
48
19
14
11
0
0
1,654
1,393
616
1,957
520
565
1,063
3,564
1,839
2,155
2,377
3,283
2,811
3,578
2,992
1,527
1,185
465
311
414
303
695
171
164
157
150
143
165
155
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,749
14,064
0
12,723
0
0
0
00012,723014,06414,749000000000000001551651431501571641716953034143114651,1851,5272,9923,5782,8113,2832,3772,1551,8393,5641,0635655201,9576161,3931,654001114194847544936404345495154000000000000000
> Total Stockholder Equity
0
0
0
118
0
0
0
446
0
-69
2,825
19,847
19,847
17,828
17,188
16,323
15,000
12,746
14,082
10,560
7,671
5,974
4,763
7,618
6,655
5,412
6,001
5,518
6,283
4,954
3,875
3,761
2,717
6,411
9,395
14,622
14,622
9,844
22,119
21,391
17,638
41,188
36,623
35,242
66,622
62,792
60,650
55,476
50,537
46,325
42,903
39,309
35,096
33,969
31,729
80,964
76,246
71,062
64,077
50,784
51,176
63,282
77,983
87,630
99,676
111,201
156,628
169,598
178,651
188,944
198,661
206,831
220,221
241,092
270,041
300,421
333,661
375,294
348,548
387,881
561,412
561,412387,881348,548375,294333,661300,421270,041241,092220,221206,831198,661188,944178,651169,598156,628111,20199,67687,63077,98363,28251,17650,78464,07771,06276,24680,96431,72933,96935,09639,30942,90346,32550,53755,47660,65062,79266,62235,24236,62341,18817,63821,39122,1199,84414,62214,6229,3956,4112,7173,7613,8754,9546,2835,5186,0015,4126,6557,6184,7635,9747,67110,56014,08212,74615,00016,32317,18817,82819,84719,8472,825-690446000118000
   Common Stock
0
0
0
29
0
0
0
69
0
69
7
13
13
13
13
13
13
13
14
14
14
14
14
18
18
18
19
19
22
22
22
25
25
31
35
41
41
41
54
54
54
67
67
69
82
82
83
83
83
83
83
83
83
85
85
103
103
103
103
103
103
103
103
103
103
103
104
104
104
103
103
103
103
103
104
105
106
107
107
107
118
118107107107106105104103103103103103104104104103103103103103103103103103103103858583838383838383828269676754545441414135312525222222191918181814141414141313131313131376906900029000
   Retained Earnings Total Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-34,623
-35,751
-38,103
-39,192
-39,481
-42,102
-42,179
-43,923
-47,067
-52,979
-54,334
-58,145
-61,343
-66,353
-69,843
-75,253
-79,811
-84,260
-90,076
-95,462
-100,031
-103,985
-108,148
-113,115
-116,995
-121,173
-126,560
-132,260
-138,225
-146,064
-160,564
-161,208
-150,249
-136,618
-128,689
-118,263
-108,483
-65,143
0
-46,335
-37,821
-32,544
-26,310
-15,620
1,643
24,391
49,862
79,430
0
0
0
0
000079,43049,86224,3911,643-15,620-26,310-32,544-37,821-46,3350-65,143-108,483-118,263-128,689-136,618-150,249-161,208-160,564-146,064-138,225-132,260-126,560-121,173-116,995-113,115-108,148-103,985-100,031-95,462-90,076-84,260-79,811-75,253-69,843-66,353-61,343-58,145-54,334-52,979-47,067-43,923-42,179-42,102-39,481-39,192-38,103-35,751-34,62300000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
-2
0
-4
-6
-7
-7
-11
-15
-22
-31
-39
-47
-55
-63
-71
-78
-85
-92
-98
-105
-111
-112
-133
-141
-59
-62
-65
-67
-70
-70
-81
-87
-92
-92
-98
-105
-113
-121
-130
-100
-70
-83
-92
-102
-113
-126
-139
-152
-159
-22
-36
-46
-20
-7
22
19
10
84
-1
-6
31
-45
-37
-63
-148
-453
-130
32
24
11
19
15
14
0
0141519112432-130-453-148-63-37-4531-6-184101922-7-20-46-36-22-159-152-139-126-113-102-92-83-70-100-130-121-113-105-98-92-92-87-81-70-70-67-65-62-59-141-133-112-111-105-98-92-85-78-71-63-55-47-39-31-22-15-11-7-7-6-40-20000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
39,555
39,604
41,839
41,884
45,861
51,463
56,760
56,801
56,870
75,044
75,671
75,729
102,464
102,908
105,016
141,793
142,521
144,827
145,469
145,916
146,273
146,805
147,374
148,128
150,880
152,817
207,422
208,426
209,222
210,084
211,265
212,288
213,405
214,478
216,206
217,751
219,582
221,673
0
224,927
226,699
231,165
233,186
236,191
239,476
245,514
250,430
254,114
0
0
0
0
0000254,114250,430245,514239,476236,191233,186231,165226,699224,9270221,673219,582217,751216,206214,478213,405212,288211,265210,084209,222208,426207,422152,817150,880148,128147,374146,805146,273145,916145,469144,827142,521141,793105,016102,908102,46475,72975,67175,04456,87056,80156,76051,46345,86141,88441,83939,60439,55500000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
1,312
0
0
0
3,408
0
3,562
7,842
0
25,600
26,047
26,144
26,231
26,501
26,632
30,830
31,065
31,215
31,287
31,370
35,390
35,480
35,572
37,069
37,321
39,602
39,689
39,745
41,898
41,946
45,926
51,530
0
56,830
56,951
75,131
75,763
75,821
102,562
103,013
105,129
141,915
142,652
144,927
145,539
145,999
146,365
146,907
147,488
148,255
151,019
152,969
207,581
208,426
209,222
210,084
211,265
212,288
213,405
214,478
216,206
217,751
219,582
221,673
223,168
224,927
226,699
231,165
233,186
236,191
239,476
245,514
250,430
254,114
257,976
261,998
266,488
416,747
416,747266,488261,998257,976254,114250,430245,514239,476236,191233,186231,165226,699224,927223,168221,673219,582217,751216,206214,478213,405212,288211,265210,084209,222208,426207,581152,969151,019148,255147,488146,907146,365145,999145,539144,927142,652141,915105,129103,013102,56275,82175,76375,13156,95156,830051,53045,92641,94641,89839,74539,68939,60237,32137,06935,57235,48035,39031,37031,28731,21531,06530,83026,63226,50126,23126,14426,04725,60007,8423,56203,4080001,312000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue398,204
Cost of Revenue-84,532
Gross Profit313,672313,672
 
Operating Income (+$)
Gross Profit313,672
Operating Expense-226,860
Operating Income86,81286,812
 
Operating Expense (+$)
Research Development93,150
Selling General Administrative47,021
Selling And Marketing Expenses86,689
Operating Expense226,860226,860
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income86,812
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)94,51179,113
EBIT - interestExpense = 86,812
94,511
71,410
Interest Expense0
Earnings Before Interest and Taxes (EBIT)86,81294,511
Earnings Before Interest and Taxes (EBITDA)119,955
 
After tax Income (+$)
Income Before Tax94,511
Tax Provision-18,775
Net Income From Continuing Ops62,03775,736
Net Income71,410
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses311,392
Total Other Income/Expenses Net7,6990
 

Technical Analysis of Catalyst Pharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Catalyst Pharmaceuticals Inc. The general trend of Catalyst Pharmaceuticals Inc is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Catalyst Pharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Catalyst Pharmaceuticals Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 15.75 < 16.60 < 17.03.

The bearish price targets are: 14.59 > 14.47 > 13.12.

Tweet this
Catalyst Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Catalyst Pharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Catalyst Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Catalyst Pharmaceuticals Inc. The current macd is -0.0777404.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Catalyst Pharmaceuticals Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Catalyst Pharmaceuticals Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Catalyst Pharmaceuticals Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Catalyst Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartCatalyst Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Catalyst Pharmaceuticals Inc. The current adx is 13.82.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Catalyst Pharmaceuticals Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Catalyst Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Catalyst Pharmaceuticals Inc. The current sar is 14.77.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Catalyst Pharmaceuticals Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Catalyst Pharmaceuticals Inc. The current rsi is 54.79. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Catalyst Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartCatalyst Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Catalyst Pharmaceuticals Inc. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Catalyst Pharmaceuticals Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Catalyst Pharmaceuticals Inc Daily Stochastic Oscillator ChartCatalyst Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Catalyst Pharmaceuticals Inc. The current cci is 66.96.

Catalyst Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartCatalyst Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Catalyst Pharmaceuticals Inc. The current cmo is 20.47.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Catalyst Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartCatalyst Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Catalyst Pharmaceuticals Inc. The current willr is -13.93442623.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Catalyst Pharmaceuticals Inc Daily Williams %R ChartCatalyst Pharmaceuticals Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Catalyst Pharmaceuticals Inc. The current atr is 0.46076262.

Catalyst Pharmaceuticals Inc Daily Average True Range (ATR) ChartCatalyst Pharmaceuticals Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Catalyst Pharmaceuticals Inc. The current obv is 71,090,072.

Catalyst Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartCatalyst Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Catalyst Pharmaceuticals Inc. The current mfi is 77.97.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Catalyst Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartCatalyst Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Catalyst Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-29BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-06MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-23BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-05-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Catalyst Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Catalyst Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.788
Ma 20Greater thanMa 5015.461
Ma 50Greater thanMa 10015.599
Ma 100Greater thanMa 20015.476
OpenGreater thanClose15.730
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Catalyst Pharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on Catalyst Pharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Catalyst Pharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Catalyst Pharmaceuticals Inc

I send you an email if I find something interesting about Catalyst Pharmaceuticals Inc.


Stay informed about Catalyst Pharmaceuticals Inc.

Receive notifications about Catalyst Pharmaceuticals Inc in your mailbox!